223 related articles for article (PubMed ID: 20396886)
1. 18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning.
Nunes ML; Rault A; Teynie J; Valli N; Guyot M; Gaye D; Belleannee G; Tabarin A
World J Surg; 2010 Jul; 34(7):1506-10. PubMed ID: 20396886
[TBL] [Abstract][Full Text] [Related]
2. 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients.
Groussin L; Bonardel G; Silvéra S; Tissier F; Coste J; Abiven G; Libé R; Bienvenu M; Alberini JL; Salenave S; Bouchard P; Bertherat J; Dousset B; Legmann P; Richard B; Foehrenbach H; Bertagna X; Tenenbaum F
J Clin Endocrinol Metab; 2009 May; 94(5):1713-22. PubMed ID: 19190108
[TBL] [Abstract][Full Text] [Related]
3. [Use of 18F-FDG-positron emission tomography in presurgical evaluation of nonspecific or suspectious adrenal masses in non-oncologic patients].
Pavón-Paz I; Rosado-Sierra JA; Balsa-Bretón MÁ; Guijarro-Armas G; Merino-Viveros M; Penín-Gonzalez FJ
Med Clin (Barc); 2016 Feb; 146(3):104-7. PubMed ID: 26343158
[TBL] [Abstract][Full Text] [Related]
4. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
5. Characterization of adrenocortical tumors by
Paladino NC; Guérin C; Lowery A; Attard A; Essamet W; Slotema E; Morange I; Castinetti F; Brue T; Loundou A; Taïeb D; Sebag F
Surg Oncol; 2018 Jun; 27(2):231-235. PubMed ID: 29937176
[TBL] [Abstract][Full Text] [Related]
6. Analysis of adrenal masses by 18F-FDG positron emission tomography scanning.
Han SJ; Kim TS; Jeon SW; Jeong SJ; Yun M; Rhee Y; Kang ES; Cha BS; Lee EJ; Lee HC; Lim SK
Int J Clin Pract; 2007 May; 61(5):802-9. PubMed ID: 17343665
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients.
Tenenbaum F; Groussin L; Foehrenbach H; Tissier F; Gouya H; Bertherat J; Dousset B; Legmann P; Richard B; Bertagna X
Eur J Endocrinol; 2004 Jun; 150(6):789-92. PubMed ID: 15191348
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
Ardito A; Massaglia C; Pelosi E; Zaggia B; Basile V; Brambilla R; Vigna-Taglianti F; Duregon E; Arena V; Perotti P; Penna D; Terzolo M
Eur J Endocrinol; 2015 Dec; 173(6):749-56. PubMed ID: 26346137
[TBL] [Abstract][Full Text] [Related]
9. The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas.
Humbert AL; Lecoanet G; Moog S; Bouderraoui F; Bresler L; Vignaud JM; Chevalier E; Brunaud L; Klein M; Cuny T
Endocrine; 2018 Mar; 59(3):529-537. PubMed ID: 29332161
[TBL] [Abstract][Full Text] [Related]
10. Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study.
Guerin C; Pattou F; Brunaud L; Lifante JC; Mirallié E; Haissaguerre M; Huglo D; Olivier P; Houzard C; Ansquer C; Hindié E; Loundou A; Archange C; Tabarin A; Sebag F; Baumstarck K; Taïeb D
J Clin Endocrinol Metab; 2017 Jul; 102(7):2465-2472. PubMed ID: 28431167
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT image findings of a dog with adrenocortical carcinoma.
Lee D; Yun T; Koo Y; Chae Y; Chang D; Yang MP; Kang BT; Kim H
BMC Vet Res; 2022 Jan; 18(1):15. PubMed ID: 34980137
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of benign adrenocortical adenomas with 18F-FDG PET accumulation.
Ishiwata K; Suzuki S; Igarashi K; Ruike Y; Naito K; Ishida A; Deguchi-Horiuchi H; Fujimoto M; Koide H; Imamura Y; Sakamoto S; Ichikawa T; Ikeda JI; Yokote K
Eur J Endocrinol; 2021 Jun; 185(1):155-165. PubMed ID: 33960957
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies - a multicenter experience.
Cistaro A; Niccoli Asabella A; Coppolino P; Quartuccio N; Altini C; Cucinotta M; Alongi P; Balma M; Sanfilippo S; Buschiazzo A; Piccardo A; Fanelli M; Sambuceti G; Bomanji J; Baldari S; Bisi G; Fanti S; Rubini G
Hell J Nucl Med; 2015; 18(2):97-102. PubMed ID: 26187207
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of unenhanced computed tomography and
Delivanis DA; Bancos I; Atwell TD; Schmit GD; Eiken PW; Natt N; Erickson D; Maraka S; Young WF; Nathan MA
Clin Endocrinol (Oxf); 2018 Jan; 88(1):30-36. PubMed ID: 28815667
[TBL] [Abstract][Full Text] [Related]
15. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT in the evaluation of adrenal masses in lung cancer patients.
Lu Y; Xie D; Huang W; Gong H; Yu J
Neoplasma; 2010; 57(2):129-34. PubMed ID: 20099976
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation.
Ansquer C; Scigliano S; Mirallié E; Taïeb D; Brunaud L; Sebag F; Leux C; Drui D; Dupas B; Renaudin K; Kraeber-Bodéré F
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(9):1669-78. PubMed ID: 20490488
[TBL] [Abstract][Full Text] [Related]
18. Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors.
Gust L; Taieb D; Beliard A; Barlier A; Morange I; de Micco C; Henry JF; Sebag F
World J Surg; 2012 Jun; 36(6):1406-10. PubMed ID: 22131094
[TBL] [Abstract][Full Text] [Related]
19. Characterization of lipid-rich adrenal tumors by FDG PET/CT: Are they hormone-secreting or not?
Takanami K; Kaneta T; Morimoto R; Satoh F; Nakamura Y; Takase K; Takahashi S
Ann Nucl Med; 2014 Feb; 28(2):145-53. PubMed ID: 24272068
[TBL] [Abstract][Full Text] [Related]
20. The Diagnostic Value of 18F-FDG PET/CT Scan in Characterizing Adrenal Tumors.
Schaafsma M; Berends AMA; Links TP; Brouwers AH; Kerstens MN
J Clin Endocrinol Metab; 2023 Aug; 108(9):2435-2445. PubMed ID: 36948598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
